Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...13, 14, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-05-24
4:52 pm
Sale
13DVectivBio Holding AG
VECT
ORBIMED ADVISORS LLC5,156,561
7.7%
-1,557,000decrease
(-23.19%)
View
2023-05-24
4:47 pm
Purchase
13DPrelude Therapeutics Incorporated
PRLD
ORBIMED ADVISORS LLC15,716,642
28.6%
869,565increase
(+5.86%)
View
2023-05-17
4:46 pm
Sale
13DSpringWorks Therapeutics, Inc.
SWTX
ORBIMED ADVISORS LLC4,178,588
6.7%
-806,412decrease
(-16.18%)
View
2023-05-16
4:28 pm
Unchanged
13DFusion Pharmaceuticals Inc.
FUSN
ORBIMED ADVISORS LLC2,930,670
4.6%
0
(Unchanged)
View
2023-05-16
4:25 pm
Sale
13DVerona Pharma plc
VRNA
ORBIMED ADVISORS LLC3,777,778
4.8%
-482,913decrease
(-11.33%)
View
2023-05-08
5:01 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.2%
1,460,932increase
(+23.95%)
View
2023-05-05
11:14 am
Unchanged
13DXtant Medical Holdings, Inc.
XTNT
ORBIMED ADVISORS LLC73,114,592
67.1%
0
(Unchanged)
View
2023-05-02
7:28 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC6,098,797
13.1%
1,405,168increase
(+29.94%)
View
2023-04-21
5:03 pm
Sale
13DTELA Bio, Inc.
TELA
ORBIMED ADVISORS LLC2,866,267
11.9%
-192,000decrease
(-6.28%)
View
2023-04-11
7:10 pm
Purchase
13DApollomics Inc.ORBIMED ADVISORS LLC662,561
10.3%
662,561increase
(New Position)
View
2023-04-07
4:38 pm
Sale
13DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC2,696,654
10.5%
-74,790decrease
(-2.70%)
View
2023-03-31
4:48 pm
Purchase
13DGracell Biotechnologies Inc.
GRCL
ORBIMED ADVISORS LLC7,583,576
11.2%
1,612,904increase
(+27.01%)
View
2023-03-29
5:24 pm
Unchanged
13DTerns Pharmaceuticals, Inc.
TERN
ORBIMED ADVISORS LLC7,619,135
13.4%
0
(Unchanged)
View
2023-03-24
4:57 pm
Unchanged
13DCalciMedica Inc.
GRAY
ORBIMED ADVISORS LLC297,380
5.4%
0
(Unchanged)
View
2023-03-24
4:43 pm
Sale
13D89bio, Inc.
ETNB
ORBIMED ADVISORS LLC0
0%
-1,504,436decrease
(Position Closed)
View
2023-03-22
4:27 pm
Sale
13DCalciMedica IncORBIMED ADVISORS LLC297,380
18.9%
-3,865,967decrease
(-92.86%)
View
2023-03-14
4:19 pm
Purchase
13DTheseus Pharmaceuticals, Inc.
THRX
ORBIMED ADVISORS LLC17,233,668
39.6%
395,000increase
(+2.35%)
View
2023-02-28
5:09 pm
Sale
13DFusion Pharmaceuticals Inc.
FUSN
ORBIMED ADVISORS LLC2,930,670
4.7%
-67,311decrease
(-2.25%)
View
2023-02-28
4:00 pm
Purchase
13DEnliven Therapeutics Inc.
IMRA
ORBIMED ADVISORS LLC8,949,339
21.8%
8,949,339increase
(New Position)
View
2023-02-23
3:23 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC4,693,629
10.6%
1,295,700increase
(+38.13%)
View
Goto 0, 1, 2, ...13, 14, Next